Evidence map›Paper›PMID 39929971›Full record

ArticleScientific reports2025

Impact of public versus non public insurance on hispanic kidney transplant outcomes using UNOS database.

Charat Thongprayoon, Oscar A Garcia Valencia, Caroline C Jadlowiec, Shennen A Mao, Michael A Mao, Napat Leeaphorn, Justin H Pham, Eva Csongradi, Iasmina M Craici, Pooja Budhiraja and 1 more

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Charat ThongprayoonDivision of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
Oscar A Garcia ValenciaDivision of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
Caroline C JadlowiecDivision of Transplant Surgery, Mayo Clinic, Phoenix, AZ, USA.
Shennen A MaoDivision of Transplant Surgery, Mayo Clinic, Jacksonville, FL, USA.
Michael A MaoDivision of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Jacksonville, FL, USA.
Napat LeeaphornDivision of Transplant Surgery, Mayo Clinic, Jacksonville, FL, USA.
Justin H PhamMayo Clinic College of Medicine and Science, Mayo Clinic, Rochester, MN, USA.
Eva CsongradiFaculty of Medicine, University of Debrecen, Debrecen, Hungary.
Iasmina M CraiciDivision of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
Pooja BudhirajaDivision of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Phoenix, AZ, USA.
Wisit CheungpasitpornDivision of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, MN, USA. wcheungpasitporn@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Disparities in access to care and transplantation outcomes, including prolonged waitlist times and reduced living donor transplantation rates, are well-documented in Hispanic kidney transplant patients. While post-transplant graft and patient survival rates are generally comparable to those of non-Hispanic white patients, variability within the Hispanic population is driven by socioeconomic and clinical factors. Insurance type may be a crucial determinant of both access to transplantation and post-transplantation outcomes, warranting a focused study of its impact within this population. We used the OPTN/UNOS database to identify Hispanic kidney-only transplant recipients in the United States between 2015 and 2019. We categorized patients by insurance type to public versus non-public insurance. We compared risk of graft failure and death after kidney transplant between the public and non-public insurance groups. Of 14,639 Hispanic kidney transplant recipients, 10,761 (74%) had public insurance. Public insurance group were older, had more kidney retransplant, more deceased donor but less preemptive kidney transplant, longer dialysis duration, more diabetes, peripheral vascular disease, reduced functional status, and were less likely to be employed or have high education level compared to non-public insurance group. Public insurance was significantly associated with an increased risk of death-censored graft failure (HR 1.36; 95% CI 1.16-1.60) and patient death (HR 1.15; 95% CI 1.01-1.30). Similarly, public insurance was significantly associated with an increased risk of graft failure when accounting for death as the competing risk. Disparities in post-transplant outcomes were observed between Hispanic kidney recipients with public versus non-public insurance. Public insurance was a significant predictor for reduced graft and patient survival after kidney transplant.

Indexed as

Hispanic or LatinoInsurance, HealthKidney TransplantationAdultDatabases, FactualFemaleGraft SurvivalHealthcare DisparitiesHumansMaleMiddle AgedTreatment OutcomeUnited StatesWhiteGraft failureHealth disparitiesHispanicInsurance typeKidney transplantNon-public insuranceOPTN/UNOS databasePatient survivalPublic insuranceSocioeconomic factors

Identifiers

PMID39929971
PMCPMC11811044

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.